Lucira Health, Loch Lomond announce study on Lucira COVID-19 & Flu Test

Lucira Health and Loch Lomond Villa announced a clinical study to simultaneously test residents, medical and support staff, and visitors for COVID-19 and Influenza A/B infection with the Lucira COVID-19 & Flu Test. This pilot will enhance testing and tracking capabilities at Loch Lomond Villa, while allowing medical staff to conduct a comparative and observational study that will help assess the effectiveness of Lucira’s testing platform in managing and minimizing COVID-19 and Influenza A/B outbreaks in long-term care settings. "Lucira’s test means that Canadians no longer need to trade-off speed for accuracy when testing for infection," said Erik Engelson, President and Chief Executive Officer of Lucira Health. "This is the only portable molecular self-test for COVID-19 and the flu on the market, providing lab-quality test results, at home and work, in hospitals or while travelling."